Alerts will be sent to your verified email
Verify Email
SHUKRAPHAR
|
Shukra Pharma
|
Amrutanjan Healthcar
|
Windlas Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.12 % | 14.67 % | 10.64 % |
|
5yr average Equity Multiplier
|
2.02 | 1.41 | 1.39 |
|
5yr Average Asset Turnover Ratio
|
0.6 | 1.22 | 1.07 |
|
5yr Avg Net Profit Margin
|
13.41 % | 8.57 % | 7.49 % |
|
Price to Book
|
28.9 | 5.98 | 3.19 |
|
P/E
|
159.02 | 36.11 | 25.28 |
|
5yr Avg Cash Conversion Cycle
|
-114.74 Days | 21.59 Days | -12.87 Days |
|
Inventory Days
|
40.87 Days | 23.18 Days | 39.91 Days |
|
Days Receivable
|
186.38 Days | 51.48 Days | 72.81 Days |
|
Days Payable
|
342.97 Days | 49.13 Days | 93.99 Days |
|
5yr Average Interest Coverage Ratio
|
23.9 | 27.21 | 42.87 |
|
5yr Avg ROCE
|
14.63 % | 24.07 % | 16.39 % |
|
5yr Avg Operating Profit Margin
|
20.24 % | 14.15 % | 12.11 % |
|
5 yr average Debt to Equity
|
0.23 | 0.12 | 0.05 |
|
5yr CAGR Net Profit
|
119.04 % | 16.38 % | 30.97 % |
|
5yr Average Return on Assets
|
8.68 % | 10.59 % | 7.71 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.96 % | 46.52 % | 61.99 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.79 % | -3.5 % | 2.04 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 1.49 % | -4.5 % |
|
Shukra Pharma
|
Amrutanjan Healthcar
|
Windlas Biotech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|